Results 181 to 190 of about 31,037 (228)

Chronic oral cannabidiol delays seizure onset and reduces seizure burden in a mouse model of CLN2 disease. [PDF]

PLoS One
Dearborn JT, Takahashi K, Rensing NR, Wong M, Cooper JD, Sands MS.   +5 more
europepmc   +1 more source

Vanilloid site-mediated TRPV3 activation by cannabidiol and potent inhibition by 14-deoxy-11,12-didehydroandrographolide. [PDF]

Cell Calcium
Kalinovskii AP, Osmakov DI, Korolkova YV, Sobolevsky AI, Andreev YA.   +4 more
europepmc   +1 more source

Cannabidiol attenuates atherosclerosis in male ApoE^-/- mice with sex-dependent lipidomic and proteomic remodeling. [PDF]

J Lipid Res
Cahová M, Ableitner E, Bechyňská K, Kučková Š, Viktorová J, Mikušová V, Kosek V, Bínová Z, Beneš F, Fabián O, Strnad O, Nejedlý T, Heczková M, Brátová M, Kaštánek P, Malý M, Hajšlová J, Mussbacher M, Stránská M.   +18 more
europepmc   +1 more source

Cannabidiol in Periodontal Therapy-Is There Hope or Just a Bias? A Systematic Review. [PDF]

Biomedicines
Ștefănescu R, Tero-Vescan A, Vari CE, Sita D, Ősz BE.   +4 more
europepmc   +1 more source

Studying Peripheral Neuropathy and Associated Neuropathic Pain in HIV-1 Transgenic Rats: Evaluation of the Therapeutic Effect of Cannabidiol and Beta-Caryophyllene. [PDF]

Pharmaceutics
Alnoud M, Rios J, Shaham SH, Tripathi MK, Benamar K.   +4 more
europepmc   +1 more source

Motor, Postural, and Communicative Phenotype in SHQ1-Related Neurodevelopmental Disorder with Dystonia and Seizures: An Interdisciplinary Case Report and Hypothesis-Generating Physiotherapy Framework. [PDF]

J Clin Med
Polczyk A, Banaszek-Hurła N, Wolańska E, Wawrzyniak J, Purpurowicz-Miękus N, Winczewska-Wiktor A, Steinborn B, Śmigiel R.   +7 more
europepmc   +1 more source